Xylem Inc.
XYL stock analysis · Industrials · Industrial Machinery & Supplies & Components
As of · fund-implied per-share value
Fund holding value ÷ shares held. Not a live quote; not adjusted for later stock splits.
View SEC fund filing ↗Price × SEC outstanding shares. Shares measured 2026-04-24. Approximate; share and price dates can differ.
View share-count filing ↗DCF value
Equity cash-flow scenario · SEC outstanding shares at 2026-04-24 · -50.8% versus input cap
How this is calculated ↗Reverse DCF
Annual basis · read assumptions below
How this is calculated ↗Relative valuation
12 industry peers · median 33.4×
How this is calculated ↗Historical multiples
7 annual observations · snapshot P/E 29.4× · -36.6% versus history
How this is calculated ↗Free cash flow yield
Annual basis · read assumptions below
How this is calculated ↗ROIC / quality
Normalized tax · financing-capital proxy
How this is calculated ↗Value composite
Annual basis · read assumptions below
How this is calculated ↗12–1 price momentum
Split and corporate-action verification is incomplete for these fund observations. Verified adjusted endpoints are required for 12–1 momentum.
How this is calculated ↗Asset growth
Annual basis · read assumptions below
How this is calculated ↗Net payout yield
Annual basis · read assumptions below
How this is calculated ↗Accrual quality
Annual basis · read assumptions below
How this is calculated ↗Fundamental momentum
Annual basis · read assumptions below
How this is calculated ↗Follow the cash
ANNUAL · USDOperating cash flow and reinvestment over time
Annual USD. Negative bars use a compressed lower scale. Hover or inspect the financial history table for exact values.
Make the assumptions yours
How sensitive is the valuation?
| Return / Growth | 3.0% | 5.0% | 7.0% |
|---|---|---|---|
| 8.0% | $72.93 | $79.58 | $86.72 |
| 10.0% | $53.45 | $58.15 | $63.20 |
| 12.0% | $42.17 | $45.75 | $49.60 |
Annual financial history
Open SEC filings ↗| Fiscal year-end | Revenue | Net income | Operating cash flow | Capital expenditure | Assets |
|---|---|---|---|---|---|
| 2025-12-31 | 9B | 950M | 1.2B | 331M | 17.6B |
| 2024-12-31 | 8.6B | 890M | 1.3B | 321M | 16.5B |
| 2023-12-31 | 7.4B | 609M | 837M | 271M | 16.1B |
| 2022-12-31 | 5.5B | 355M | 596M | 208M | 8B |
| 2021-12-31 | 5.2B | 427M | 538M | 208M | 8.3B |
| 2020-12-31 | 4.7B | 254M | 824M | 183M | 8.8B |
| 2019-12-31 | 5B | 401M | 839M | 226M | 7.7B |
| 2018-12-31 | 5B | 549M | 586M | 237M | 7.2B |
USD, abbreviated. Restated annual history; not a point-in-time backtest. Missing values appear as dashes.
Trace the inputs
MODEL ANNUAL PERIOD| Input | Value | SEC tag / source | Filed |
|---|---|---|---|
| revenue | 9B | RevenueFromContractWithCustomerExcludingAssessedTax | 2026-02-25 |
| netIncome | 950M | ProfitLoss Explicit consolidated amount, including the portion attributable to noncontrolling interests. | 2026-02-25 |
| Parent/common earnings proxy | 957M | NetIncomeLoss | 2026-02-25 |
| cfo | 1.2B | NetCashProvidedByUsedInOperatingActivities | 2026-02-25 |
| capex | 331M | PaymentsToAcquireProductiveAssets | 2026-02-25 |
| operatingIncome | 1.2B | OperatingIncomeLoss | 2026-02-25 |
| assets | 17.6B | Assets | 2026-02-25 |
| equity | 11.5B | StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest Explicit consolidated amount, including the portion attributable to noncontrolling interests. | 2026-02-25 |
| Parent book equity proxy | 11.5B | StockholdersEquity | 2026-02-25 |
| debt | 2B | LongTermDebt | 2026-02-25 |
| shortDebt | 534M | ShortTermBorrowings | 2026-02-25 |
| cash | 1.5B | CashAndCashEquivalentsAtCarryingValue | 2026-02-25 |
| shares | 244M | WeightedAverageNumberOfDilutedSharesOutstanding | 2026-02-25 |
| dividends | 391M | PaymentsOfDividendsCommonStock | 2026-02-25 |
| buybacks | 15M | PaymentsForRepurchaseOfCommonStock | 2026-02-25 |
| issuance | 20M | Reviewed manual correction Bounded FY2025-12-31 consolidated financing-statement extraction. Proceeds from exercise of employee stock options: 20000000 USD [us-gaap:ProceedsFromStockOptionsExercised]. All 8 financing lines reconcile exactly to reported financing cash flow -501000000 USD. Cash inflows from common shares, employee plans and option exercises are summed once as displayed on the statement; noncash compensation, withholding payments, preferred and noncontrolling interests are excluded. This review applies only to this issuer and fiscal period. Source limitation: the statement also aggregates other financing cash flows (net -34000000 USD). Their common-equity portion is not separately disclosed here. Issuance is the sum of separately reported common cash-issuance lines, not an independently verified gross total; additional equity flows may be inside those aggregates. | 2026-02-25 |